# Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

> **NCT00142506** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 290 (actual)

## Conditions studied

- Prostate Cancer
- Erectile Dysfunction

## Interventions

- **DRUG:** sildenafil citrate and questionaires
- **DRUG:** placebo tablets and questionaires

## Key facts

- **NCT ID:** NCT00142506
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2017-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142506, "Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00142506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*